Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation

D Darbar, PJ Kannankeril, BS Donahue, G Kucera… - Circulation, 2008 - Am Heart Assoc
D Darbar, PJ Kannankeril, BS Donahue, G Kucera, T Stubblefield, JL Haines, AL George Jr
Circulation, 2008Am Heart Assoc
Background—Genetic studies have identified ion channel gene variants in families
segregating atrial fibrillation (AF), the most common arrhythmia in clinical practice. Here, we
tested the hypothesis that vulnerability to AF is associated with variation in SCN5A, the gene
encoding the cardiac sodium channel. Methods and Results—We resequenced the entire
SCN5A coding region in 375 subjects with either lone AF (n= 118) or AF associated with
heart disease (n= 257). Controls (n= 360) from the same population were then genotyped for …
Background— Genetic studies have identified ion channel gene variants in families segregating atrial fibrillation (AF), the most common arrhythmia in clinical practice. Here, we tested the hypothesis that vulnerability to AF is associated with variation in SCN5A, the gene encoding the cardiac sodium channel.
Methods and Results— We resequenced the entire SCN5A coding region in 375 subjects with either lone AF (n=118) or AF associated with heart disease (n=257). Controls (n=360) from the same population were then genotyped for the presence of mutations or rare variants identified in the AF cases. In 10 probands (2.7%), 8 novel variants not found in the control population (0%; P=0.001) were identified. All variants affect highly conserved residues in the SCN5A protein. In 6 families with >1 affected member, the novel variant cosegregated with AF. We also identified 11 rare missense variants in 12 probands (3.2%) that have previously been associated with inherited arrhythmia syndromes (eg, congenital long-QT syndrome and Brugada syndrome).
Conclusions— Mutations or rare variants in SCN5A may predispose patients with or without underlying heart disease to AF. The findings of the present study expand the clinical spectrum of disorders of the cardiac sodium channel to include AF and represent important progress toward molecular phenotyping and directed rather than empirical therapy for this common arrhythmia.
Am Heart Assoc